The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
<p>Abstract</p> <p>Background</p> <p>Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit.</...
Main Authors: | Cantisani Teresa, Righetti Enrico, Celani Maria, Ricci Stefano, Brainin Michael, Matz Karl, Hankey Graeme, Peeters Andre, Murray Veronica, Slot Karsten, Berge Eivind, Czlonkowska Anna, Kobayashi Adam, Venables Graham, Lewis Steff, Dennis Martin, Wardlaw Joanna, Lindley Richard, Sandercock Peter, Gubitz Gord, Phillips Steve, Arauz Antonio, Prasad Kameshwar, Correia Manuel, Lyrer Phillippe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-06-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/9/1/37 |
Similar Items
-
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
by: Sandercock Peter, et al.
Published: (2011-11-01) -
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
by: Sandercock, P, et al.
Published: (2012) -
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
by: Berge, E, et al.
Published: (2016) -
The International Stroke Trial database
by: Sandercock Peter AG, et al.
Published: (2012-03-01) -
Optimizing acute stroke treatment process: insights from sub-tasks durations in a prospective observational time and motion study
by: Gizem Koca, et al.
Published: (2023-10-01)